Dr. Fred Appelbaum, former long-time president of Seattle Cancer Care Alliance, has been designated one of 15 “Giants of Cancer Care” for his contributions to leukemia research. The award, announced by digital publication OncLive, recognizes top researchers who have helped advance the understanding and treatment of cancer.
Steve Lovell treasures the infusion receptionist’s smile. Laurel Rech appreciates that her daughter’s oncologist always addressed her 12-year-old first when walking into the room, making her feel valued. Lesley Buck likes the warm blanket that staff offer her adult son, a sickle cell patient.
April is National Cancer Control Month, a time set aside to highlight the prevention and early detection of cancer. Last year, more than 1.7 million new cases of cancer were diagnosed in the U.S., and more than 609,000 people died of cancer-related causes, according to estimates from the National Cancer Institute. At the same time, the overall death rate from cancer has been decreasing. Declines in death rates for many cancers has led to an increase in the number of cancer survivors, who often have lasting complications from their treatment. At Seattle Cancer Care Alliance (SCCA), a Survivorship Clinic, support groups and social workers help people navigate life after cancer. One program in particular, SCCA's Long-Term Follow-Up Program (LTFU), supports bone marrow transplant recipients with lifelong medical check-ins and comprehensive monitoring of their health and well-being. Read on for a view into how Long-Term Follow-Up works:
Seattle Cancer Care Alliance (SCCA) and Fred Hutch physicians and researchers who are leaders in in blood and marrow transplantation will present their research at the Transplantation and Cellular Therapy Meetings (TCT, formerly the BMT Tandem Meetings). TCT are the combined annual meetings of the American Society of Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR). The full scientific program addresses the most timely issues in hematopoietic cell transplantation for investigators, clinicians, laboratory technicians, clinical research professionals, nurses, pharmacists, administrators and allied health professionals who attend the meetings.
When Ted Ave’Lallemant was diagnosed with leukemia in 2005, his oncologist in Wisconsin suggested he seek a second opinion at Seattle Cancer Care Alliance.